COVID-19 Vaccine Products

Updated September 28, 2026

For the most updated clinical guidance on COVID-19 vaccines, refer to BC Immunization Manual – Part 4 Biological Products: 

COVID-19 mRNA Vaccine SPIKEVAX® (Moderna)

• Provided in multidose vials (MDV) or prefilled syringe (PFS) formats. 
• Both MDV and PFS vaccine may be stored refrigerated at +2°C to +8°C for up to 60 days from the date of transfer from frozen storage conditions. 
• Prefilled syringes (0.5 mL) are only intended for those 12 years of age and older. 
• Resources: 
  • Health Canada: Spikevax™ Product Monograph 
  • Moderna SPIKEVAX® Dosing & Administration 

 COVID-19 mRNA Vaccine COMIRNATY® (Pfizer) Adult/Adolescent

• Approved for use in those 12 years of age and older. 
• Provided in multi-dose vials (MDV) or prefilled syringe (PFS) formats. 
• Note the different storage and handling guidance for the different formats: 
  • MDV: unopened vials may be stored refrigerated (+2°C to +8°C) for up to 10 weeks from the date of transfer from frozen storage to refrigerated storage conditions. 
  • PFS: syringes may be refrigerated (+2°C to +8°C) up until the expiry date printed on the carton and syringe labels. They are never frozen.  
• Resources: 
  • Health Canada: Comirnaty™ Product Monograph  
  • Pfizer Comirnaty™ Dosing & Administration

COVID-19 mRNA Vaccine COMIRNATY® (Pfizer) 5-11 Years of Age  

• Approved for use in those 5-11 years of age and supplied to public health only. Pharmacies will not be receiving this vaccine. 

COVID-19 Recombinant Protein, Adjuvated Vaccine NUVAXOVID® (Sanofi)

• BC is receiving limited quantities of this vaccine and will be provided by public health units.  
• Individuals 12 years of age and older who are unable to receive a COVID-19 mRNA vaccine or prefer an alternate vaccine may receive Nuvaxovid® COVID-19 XFG vaccine if available.
• Resources
  • Health Canada Nuvaxovid Product Monograph
  • Nuvaxovid Storage & Adminstration

LDV syringes/ needles

If available, use low dead-volume (LDV) syringes/needles to withdraw each dose from a multi-dose vial. If these are not used, there may be sufficient volume to extract the maximum number of doses.  

Pooling residual volume has been removed from the BCCDC Immunization Guidelines as this was a deviation from best practice in a time of minimal COVID-19 vaccine supply. As supply is no longer an issue, this deviation from best practice is no longer permitted. 

Private COVID-19 vaccines 

see Private Vaccine Supply. 

Resources

• BCCDC Part 4- Biological Product pages for COVID-19 vaccines 
• COVID-19 Vaccine Eligibility 

• HealthLink BC file #124a: COVID-19 mRNA vaccines